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During the observation period infection of female mosquitoes
was decreased from 0,9% in 2011 to 0,3% in 2014.
Conclusion: Studies have shown that in the Novgorod region
adoptable conditions are present for formation of the foci of diro-
ﬁlariasis. Detection of human diroﬁlariasis in Northwest of Russia
has been associated with delivery of infected service dogs of Min-
istry of Internal Affairs. Service dogs are regularly seconded towork
in the heartworm-endemic territories regions like as North Cauca-
sus or Southern Russia. In our view, the circulation of Diroﬁlaria
repens in the Novgorod region supports a high number of infected
dogs and a lot of vectors of transmission. Abnormally warm sum-
mers of 2010 and 2011 contributed to the development of several
generations of larvae vector transmission. These factors could lead
to the forming the foci diroﬁlariasis in the Novgorod region and the
emergence of autochthonous cases of Diroﬁlaria repens invasion in
humans.
http://dx.doi.org/10.1016/j.ijid.2016.02.808
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Background: Malaria affects almost one-half of the world’s
population and causes more than 600,000 deaths annually. Young
children in malaria endemic areas of Africa have the highest mor-
tality rate because of their immature immune systems. In previous
vaccine discovery efforts, we developed a differential screening
method using plasma from children who were resistant or sus-
ceptible to falciparum malaria. Using this approach, we discovered
PfSEA-1. Antibodies to PfSEA-1 predict resistance to severe dis-
ease in two yr old children, block schizont egress from infected
RBC in vitro, and vaccination with rPbSEA-1A protects mice from P.
berghei ANKA challenge (Raj et. al Science 2014).
Methods & Materials: We have now adapted our differen-
tial screening method to ﬁeld parasite-derived phage display
libraries. In differential bio-panning assays, PfGARP (aa 410-673)
was recognizedbyplasmapooled fromresistant (n=11) butnot sus-
ceptible (n=14) childrenparticipating inourbirthcohort inMuheza,
Tanzania. To further characterize PfGARP, we generated mouse
antibodies against this immuno-relevant, highly invariant region
(PfGARP-A) and performed growth inhibition (GIA) and immunolo-
calization studies. For GIA, 3D7 parasites were synchronized to the
ring stage and plated at 0.3-0.4% parasitemia in the presence of
anti-PfGARP-A or pre-immune sera (1:10 dilution). Parasites were
cultured for 48 hrs and ring and early trohozoite stage parasites
were enumerated.
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Results: Anti-PfGARP-A inhibited parasite growth by 99% com-
pared to controls (P<0.001). In confocal studies, PfGARP localized to
the RBCmembrane in trophozoite and early schizont infected RBCs,
but not to other parasite stages or uninfected RBC. To determine
the mechanism of growth inhibition we performed trophozoite
arrest assays (TAA) using anti-PfGARP-A. For TAA, 3D7 parasites
were synchronized to the ring stage and plated at 5% parasitemia
in the presence of anti-PfGARP-A or pre-immune mouse sera (1:10
dilution). Parasites were cultured for 36 hrs and trophozoite stage
parasites were enumerated. Anti-PfGARP-A arrested trophozoite
progression by 99% compared to controls (P < 0.001)
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Conclusion: These data support Pf-GARP as a novel vaccine can-
didate for pediatric falciparum malaria. By blocking trophozoite
development, PfGARP may synergize with vaccines targeting hep-
atocyte and red cell invasion and schizont egress.
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